TANG KEVIN purchased 3.8% of their position (249.95K shares) of FULCRUM THERAPEUTICS, INC. on the open market
Open‑market purchase worth $891.1K — a small addition. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 7/15/2026ACC: 0001178579-26-000014
+249.95K
Net shares
Net buyer
$891.1K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
249.95K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+12.97K
Price / share
$3.54
Trade value
$45.90K
% of position
0.2%
7/13/2026
6.66M→6.68M
Common Stock
Indirect
Shares
+53.65K
Price / share
$3.56
Trade value
$191K
% of position
0.8%
7/14/2026
6.68M→6.73M
Common Stock
Indirect
Shares
+75.95K
Price / share
$3.58
Trade value
$271.91K
% of position
1.1%
7/14/2026
6.73M→6.81M
Common Stock
Indirect
Shares
+107.38K
Price / share
$3.56
Trade value
$382.26K
% of position
1.6%
7/15/2026
6.81M→6.91M
Total
Net shares
+249.95K
Net value
$891.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/13/2026 | P · Purchase | +12.97K | $3.54 | $45.90K | 0.2% | 6.66M | 6.68M |
| Common Stock Indirect | 7/14/2026 | P · Purchase | +53.65K | $3.56 | $191K | 0.8% | 6.68M | 6.73M |
| Common Stock Indirect | 7/14/2026 | P · Purchase | +75.95K | $3.58 | $271.91K | 1.1% | 6.73M | 6.81M |
| Common Stock Indirect | 7/15/2026 | P · Purchase | +107.38K | $3.56 | $382.26K | 1.6% | 6.81M | 6.91M |
| Total | +249.95K | $891.07K | ||||||
Derivative Transactions0
No derivative transactions reported